SW
Therapeutic Areas
Orthogon Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Anti-polyomavirus program | BK virus infection (e.g., nephropathy in transplant patients) | Preclinical |
Leadership Team at Orthogon Therapeutics
AH
Ali H. Munawar, Ph.D.
Chief Executive Officer & Founder
MR
Mark R. Spyvee, D. Phil.
Vice President, Medicinal Chemistry